Introduction
============

Hypoxia is a major biological feature of high-altitude regions ([@ref-4]). In hypoxic environments, transcription of various genes, such as endothelial PAS domain-containing protein 1 (*EPAS1*) and prolyl hydroxylase domain-containing protein 2 (*PHD2*), is initiated by hypoxia-related pathways. An increasing number of studies show that the hypoxia-inducible factor (HIF) signaling pathway plays a vital role in the adaptation to hypoxia ([@ref-13]). The human *EPAS1* gene encodes the alpha subunit of HIF-2 (HIF-2α), which acts as a key regulator of chronic hypoxia by regulating a large number of genes ([@ref-5]).

To examine the molecular mechanisms involved in these processes, quantitative gene expression analysis is indispensable. Quantitative real-time PCR (RT-qPCR) is a highly sensitive, precise and reproducible method for the detection of gene expression levels ([@ref-6]; [@ref-8]; [@ref-27]). However, to produce optimal results from RT-qPCR analysis, minimum requirements must be met, including quality control of the mRNA and primers, PCR efficiency determination and selection of the appropriate reference genes ([@ref-18]). The obtained gene expression profile varies based on the use of different housekeeping genes as internal references genes ([@ref-23]). Therefore, proper reference gene selection guarantees the accuracy of the analysis data obtained from RT-qPCR ([@ref-27]).

Researchers have always empirically determined reference genes, such as *GAPDH* and *β-actin*, during quantitative gene expression analyses. However, recent studies have shown that housekeeping gene (HKG) expression levels vary between cell types ([@ref-11]; [@ref-19]; [@ref-28]) and experimental conditions ([@ref-25]; [@ref-30]). Thus, a stable and suitable reference gene must be selected for the normalization of target gene expression.

In the present study, three algorithms (geNorm, NormFinder and BestKeeper) were utilized to analyze the stability of selected candidate reference genes (*glyceraldehyde-3-phosphate dehydrogenase* (*GAPDH)*, *β-actin* (*ACTB)*, *18S RNA*, *β2-microglobulin* (*β2-MG)*, *peptidylprolyl isomerase A* (*PPIA)*, *ribosomal protein L13* (*RPL13A)*, *TATA-Box binding protein (TBP)* and s*uccinate dehydrogenase complex*, *subunit A* (*SDHA)*) in human blood before and after exposure to high-altitude conditions using RT-qPCR with SYBR green.

Materials and methods
=====================

Sample information
------------------

Six healthy male Han Chinese volunteers (21.3 ± 1.3 years old) who have in the plains (altitude 500 m) for at least 20 years were enrolled. Blood samples were collected when they lived in the plains and 3 days after they moved onto the plateau (altitude 4,700 m). They did not show any clinical signs of hypoxia at the time of the examination. This study was approved by the Institutional Review Board of the General Hospital of the Air Force, PLA (afgh-IRB-16-03). Each of the six volunteers provided written informed consent.

RNA samples and cDNA synthesis
------------------------------

Mononuclear cells were isolated from 5 ml of peripheral blood (before and after moving to the plateau, 3,700 m) by using lymphocyte separation medium (Solarbio, Beijing, China), as previously described ([@ref-9]). Total RNA was extracted from 10^7^ mononuclear cells using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol and then quantified using a UV-2550 spectrophotometer (Shimadzu, Kyoto, Japan). cDNA was synthetized from approximately 0.5 µg of total RNA using a ReverTra Ace®qPCR RT kit with gDNA Remover (TOYOBO, Osaka, Japan).

Candidate genes and primers for RT-qPCR
---------------------------------------

Eight candidate human reference genes, *GAPDH*, *ACTB*, *18S RNA*, *β2-MG*, *PPIA*, *RPL13A*, *TBP* and *SDHA*, were selected for evaluation based on the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines ([@ref-7]) ([Table 1](#table-1){ref-type="table"}). BLAST software was used to design the specific primers and to confirm the specificity of the primer sequences for the indicated gene. All primers, except for *18S RNA* and *β2-MG*, spanned one intron to exclude the contamination of genomic DNA in total RNA.
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###### Primer sequence information for RT-qPCR amplification used in this study.
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  Symbol    Gene name                                    Accession number                                                 Forward primer sequence \[5′--3′\]   Position in cDNA   Reverse primer sequence \[5′--3′\]   Position in cDNA   Production size
  --------- -------------------------------------------- ---------------------------------------------------------------- ------------------------------------ ------------------ ------------------------------------ ------------------ -----------------
  GAPDH     Glyceraldehyde                               [NM_002046.5](http://www.ncbi.nlm.nih.gov/nuccore/NM_002046.5)   TCCAAAATCAAGTGGGGCGA                 4th exon           TGATGACCCTTTTGGCTCCC                 5th exon           115 bp
  ACTB      β-actin                                      [NM_001101.3](http://www.ncbi.nlm.nih.gov/nuccore/NM_001101.3)   CTTCCAGCCTTCCTTCCTGG                 4th exon           CTGTGTTGGCGTACAGGTCT                 5th exon           110 bp
  18s RNA   18s RNA                                      [M10098.1](http://www.ncbi.nlm.nih.gov/nuccore/M10098.1)         GGAGCCTGCGGCTTAATTTG                                    CCACCCACGGAATCGAGAAA                                    100 bp
  β2-MG     β2-microglobulin                             [NM_004048.2](http://www.ncbi.nlm.nih.gov/nuccore/NM_004048.2)   TGGGTTTCATCCATCCGACA                 2th exon           TCAGTGGGGGTGAATTCAGTG                2 exon             138 bp
  PPIA      Peptidylprolylisomerase A                    [NM_021130.3](http://www.ncbi.nlm.nih.gov/nuccore/NM_021130.3)   GACTGAGTGGTTGGATGGCA                 4th exon           TCGAGTTGTCCACAGTCAGC                 5th exon           141 bp
  RPL13A    Ribosomal protein L13                        [NM_012423.3](http://www.ncbi.nlm.nih.gov/nuccore/NM_012423.3)   AAAAGCGGATGGTGGTTCCT                 6th exon           GCTGTCACTGCCTGGTACTT                 7th exon           118 bp
  TBP       TATA-Box binding protein                     [NM_003194.4](http://www.ncbi.nlm.nih.gov/nuccore/NM_003194.4)   CAGCTTCGGAGAGTTCTGGG                 3th exon           TATATTCGGCGTTTCGGGCA                 4th exon           117 bp
  SDHA      Succinate dehydrogenase complex, subunit A   [NM_004168.3](http://www.ncbi.nlm.nih.gov/nuccore/NM_004168.3)   AAACTCGCTCTTGGACCTGG                 10th exon          TCTTCCCCAGCGTTTGGTTT                 11th exon          111 bp

SYBR green real-time quantitative RT-PCR
----------------------------------------

PCR was performed using a CFX-96 thermocycler PCR system (Bio-Rad, Hercules, CA, USA). In each run, 1 µl of synthetized cDNA was added to 19 µl of reaction mixture containing 8 µl of H~2~O, 10 µl of THUNDERBIRD qPCR Mix (TOYOBO, Osaka, Japan) and 0.5 µl of forward and reverse primers (10 µM). Each sample was measured in triplicate. PCR was conducted at 95 °C for 3 min followed by 40 cycles of 95 °C for 10 s, 58 °C for 15 s and 72 °C for 15 s. The amplification was followed by melting curve analysis.

Amplification efficiency and primer specificity of the reference genes
----------------------------------------------------------------------

The amplification efficiency (*E*) of the primers was tested using a standard curve RT-qPCR of a serially diluted (1/10, 1/100, 1/1,000, 1/10,000, and 1/100,000) cDNA sample with the formula *E*(%) = (10^−1∕slope^ − 1) × 100 ([@ref-1]). The efficiency (*E*) and correlation coefficient (*R*^2^) of each candidate reference gene were calculated to determine amplification efficiency ([Table 2](#table-2){ref-type="table"}). An amplification efficiency of 90--110% and an *R*^2^ of 0.99 were acceptable.
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###### RT-qPCR analysis for determination of the amplification efficiency.
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  Gene      Slope    *E* (%)   *R*^2^
  --------- -------- --------- --------
  GAPDH     −3.162   107.1     0.999
  ACTB      −3.432   95.6      0.997
  18s RNA   −3.422   96.0      0.998
  β2-MG     −3.302   100.8     0.998
  PPIA      −3.014   114.7     0.990
  RPL13A    −3.254   102.9     0.999
  TBP       −3.227   104.1     0.997
  SDHA      −3.199   105.4     0.997

**Notes.**

*E*efficiency*R*^2^correlation coefficient

Analysis of reference gene expression stability
-----------------------------------------------

The *geNorm* ([@ref-27]) program was used to measure gene expression stability (*M*), and this method differs from model-based approaches by comparing genes based on the similarity of their expression profiles. *geNorm* ranks the genes based on *M* values, where the gene with the most stable expression has the lowest value. *NormFinder* ([@ref-2]) was used to find two genes with the least intra- and inter-group expression variation. A BestKeeper index was created using the geometric mean of the *Ct* values of each candidate gene. An estimation of the reference gene stability could be obtained by analyzing the calculated variation (standard deviation and coefficient variance) ([@ref-21]).

Finally, RefFinder, a comprehensive web-based tool that integrates geNorm, NormFinder and BestKeeper, was applied to determine the most stable reference gene for the final ranking ([@ref-16]).

Results
=======

Determining the specificity and amplification efficiency of the primers
-----------------------------------------------------------------------

The expression stability of eight candidate reference genes in subjects before and after migrating onto the plateau was analyzed using RT-qPCR. For each reference gene, primer specificity was demonstrated by a single peak in the melting curve analysis ([Fig. 1](#fig-1){ref-type="fig"}). Amplification efficiencies were calculated as previously described ([@ref-1]) and ranged from 95.6% to 114.7% for the eight reference genes. The correlation coefficient (*R*^2^) of the standard curve for each gene was greater than 0.98 ([Table 2](#table-2){ref-type="table"}).

![Specificity of RT-qPCR amplicons.\
Dissociation curves with single peaks were generated from all amplicons and showed no dimer formation for each reference gene.](peerj-05-3726-g001){#fig-1}

Expression levels of reference genes in the blood before and after migrating onto the plateau
---------------------------------------------------------------------------------------------

To examine the stability of eight HKGs before and after migrating onto the plateau, the expression levels were evaluated by RT-qPCR, and the Shapiro--Wilk test was used to evaluate the normality of the *Ct* values ([Table 3](#table-3){ref-type="table"}). The *Ct* values ranged from 13.40 (*ACTB*) to 21.34 (*TBP*) for the blood samples before ascending to the plateau ([Table 3](#table-3){ref-type="table"} and [Fig. 2A](#fig-2){ref-type="fig"}) and 13.60 (*RPL13A*) to 21.78 (*TBP*) for the samples taken after ascending to the plateau ([Table 3](#table-3){ref-type="table"} and [Fig. 2B](#fig-2){ref-type="fig"}). *ACTB* and *RPL13A* were more abundantly expressed than the other genes before and after migrating onto the plateau ([Fig. 2](#fig-2){ref-type="fig"}).

Candidate reference gene stability: geNorm
------------------------------------------

Candidate reference gene stability was evaluated based on the *M* values of the genes using the *geNorm* algorithm ([@ref-27]). The *M* values for *GAPDH, ACTB, 18S RNA, β2-MG, PPIA, RPL13A, TBP* and *SDHA* were lower than 1.5 in all samples. According to the analysis, *GAPDH* and *ACTB* were the most stable among all eight candidate genes on the plains ([Fig. 3A](#fig-3){ref-type="fig"}), whereas *18S RNA* and *RPL13A* were the most stable genes on the plateau ([Fig. 3B](#fig-3){ref-type="fig"}). Analysis of samples from both stages confirmed that *GAPDH* and *RPL13A* were the most stable genes ([Fig. 3C](#fig-3){ref-type="fig"}).
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###### Descriptive statistics and normality evaluation of the reference genes *Cq* values before and after entering plateau.

![](peerj-05-3726-g006)

                   Gene      Mean    SD     Min *Cq*   Max *Cq*   SW-test *p*
  ---------------- --------- ------- ------ ---------- ---------- -------------
  Before plateau   GAPDH     18.41   0.09   18.31      18.52      0.248
                   ACTB      13.40   0.13   13.25      13.63      0.601
                   18s RNA   15.84   0.56   14.79      16.63      0.989
                   β2-MG     15.86   0.30   15.46      16.25      0.326
                   PPIA      16.82   0.18   16.66      17.09      0.095
                   RPL13A    13.88   0.10   13.71      14.00      0.620
                   TBP       21.34   0.26   20.96      21.75      0.996
                   SDHA      19.79   0.26   19.41      20.17      0.963
  After plateau    GAPDH     18.01   0.28   17.68      18.40      0.664
                   ACTB      14.35   0.43   13.84      14.89      0.526
                   18s RNA   15.79   0.29   15.32      16.10      0.616
                   β2-MG     16.43   0.45   15.71      16.90      0.661
                   PPIA      16.96   0.30   16.38      17.26      0.089
                   RPL13A    13.60   0.15   13.39      13.77      0.486
                   TBP       21.78   0.73   20.50      22.60      0.530
                   SDHA      20.11   0.32   19.67      20.57      0.987

**Notes.**

SDstandard deviationMin *Cq*minimum *Cq* valueMax *Cq*maximum *Cq* valueSW-test *pp*-value of the Shapiro--Wilk test

![Candidate reference gene *Ct* value distributions.\
Boxplots of the *Ct* values from six volunteers from the plain (A) and the plateau (B) stages for each of the eight candidate reference genes.](peerj-05-3726-g002){#fig-2}

Using the *geNorm* algorithm, the pairwise variation value (*V*~*n*~∕*V*~*n*+1~) was used to calculate the optimum number of reference genes for accurate normalization and to determine whether the addition of another reference gene (*n* + 1) for normalization was recommended. A cut-off threshold (*V*~*n*~∕*V*~*n*+1~ = 0.15) was used to determine the optimal number of reference genes required for normalization ([@ref-27]). The greater the number of reference genes used for normalization, the more confidence there is in their gene expression level ([@ref-12]). Two reference genes were sufficient for gene expression analysis of the blood in the plains ([Fig. 3D](#fig-3){ref-type="fig"}) and plateau stages ([Fig. 3E](#fig-3){ref-type="fig"}). When all samples were analyzed together, the *Vn*∕*Vn* + 1 values ranged from 0.062 to 0.110 and were all lower than the threshold value of 0.15 ([Fig. 3F](#fig-3){ref-type="fig"}). Thus, only two HKGs are required for the normalization of target genes in expression analyses.

![The geNorm selection analysis of candidate reference genes.\
The average expression stability value (*M*) was calculated by geNorm for each gene on the plain (A), plateau (B) or both stages (C). Pairwise variation (*V*) between the normalization factors (*Vn* and *Vn* + 1) was used to determine the optimal number of reference genes for normalization on the plain (D), plateau (E) or both stages (F).](peerj-05-3726-g003){#fig-3}

Candidate reference gene stability: NormFinder
----------------------------------------------

The *NormFinder* algorithm ranks the HKGs according to the inter- and intra-group variations in expression ([@ref-1]). The results indicated that *GAPDH*, *PL13A*, *ACTB* and *PPIA* in the plains group ([Table 4](#table-4){ref-type="table"}) and *PPIA*, *SDHA*, *ACTB* and *RPL13A* in the plateau group ([Table 4](#table-4){ref-type="table"}) were the most stable reference genes. *PPIA*, *SDHA, TBP* and *RPL13A* were the four most stable reference genes in both groups ([Table 4](#table-4){ref-type="table"}).
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###### Calculation of candidate reference genes expression stability by the *NormFinder*.
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  Ranking order   Gene      Stability value (Whole stages)   Gene      Stability value (Plain)   Gene      Stability value (plateau)
  --------------- --------- -------------------------------- --------- ------------------------- --------- ---------------------------
  1               PPIA      0.080                            GAPDH     0.032                     PPIA      0.076
  2               SDHA      0.136                            RPL13A    0.057                     SDHA      0.166
  3               TBP       0.205                            ACTB      0.110                     ACTB      0.176
  4               RPL13A    0.227                            PPIA      0.121                     RPL13A    0.182
  5               18s RNA   0.229                            TBP       0.167                     18s RNA   0.194
  6               β2-MG     0.237                            SDHA      0.210                     GAPDH     0.237
  7               GAPDH     0.265                            β2-MG     0.264                     β2-MG     0.244
  8               ACTB      0.316                            18s RNA   0.434                     TBP       0.369

Candidate reference gene stability: BestKeeper
----------------------------------------------

The *BestKeeper* algorithm ([@ref-21]) uses the coefficient variance (*CV*) and standard deviation (SD) of candidate gene expression to determine the optimal HKGs ([Table 5](#table-5){ref-type="table"}). In the *BestKeeper* program, HKGs with lower SD and *CV* values are considered as optimal reference genes. In both stages, *RPL13A* expression had the lowest SD (0.15) and the lowest *CV* (1.10). Therefore, *RPL13A* was proposed as the ideal HKG for the analysis of gene expression during the plains and plateau stages.
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###### Results from BestKeeper analysis.
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  Gene                        Whole stage   Plain   Plateau
  --------- ----------------- ------------- ------- ---------
  GAPDH     std dev \[±CP\]   0.24          0.08    0.23
            CV \[% CP\]       1.33          0.41    1.25
  ACTB      std dev \[±CP\]   0.48          0.11    0.35
            CV \[% CP\]       3.45          0.82    2.45
  18s RNA   std dev \[±CP\]   0.33          0.44    0.23
            CV \[% CP\]       2.09          2.79    1.45
  β2-MG     std dev \[±CP\]   0.37          0.26    0.33
            CV \[% CP\]       2.31          1.63    2.04
  PPIA      std dev \[±CP\]   0.21          0.16    0.19
            CV \[% CP\]       1.24          0.93    1.15
  RPL13A    std dev \[±CP\]   0.15          0.09    0.12
            CV \[% CP\]       1.10          0.62    0.89
  TBP       std dev \[±CP\]   0.43          0.22    0.53
            CV \[% CP\]       1.98          1.01    2.42
  SDHA      std dev \[±CP\]   0.27          0.23    0.25
            CV \[% CP\]       1.34          1.15    1.22

Candidate reference gene stability: RefFinder
---------------------------------------------

Based on the geNorm, NormFinder and BestKeeper results, RefFinder (<http://leonxie.esy.es/RefFinder/>) was used to calculate a comprehensive expression stability ranking. As shown in [Table 6](#table-6){ref-type="table"}, *GAPDH* (plains) and *PPIA* (plateau) were the most stable HKGs before and after entering the plateau, respectively. Across both stages, *PPIA* and *RPL13A* were the most stable reference genes for the normalization of target gene expression levels.
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###### Stabilities of HKGs ranked by RefFinder.
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  Ranking order   Whole stages   Plain    Plateau
  --------------- -------------- -------- ---------
  1               PPIA           GAPDH    PPIA
  2               RPL13A         RPL13A   RPL13A
  3               SDHA           ACTB     18sRNA
  4               GAPDH          PPIA     SDHA
  5               β2-MG          TBP      GAPDH
  6               TBP            SDHA     ACTB
  7               18sRNA         β2-MG    β2-MG
  8               ACTB           18sRNA   TBP

Discussion
==========

Understanding the mechanisms of high-altitude hypoxic adaptation is a major focus of high-altitude medical research. Using RT-qPCR to rapidly and accurately analyze gene expression is a common strategy for understanding the mechanisms of this process ([@ref-26]). Since the expression levels of reference genes in endothelial cells ([@ref-3]), epithelial cells ([@ref-15]) and cancer cells ([@ref-10]; [@ref-14]) can vary under hypoxic conditions, gene expression was analyzed in blood from subjects at various altitudes to determine which reference genes should be used under particular conditions. Most expression studies of blood under hypoxic conditions have used a single traditional reference gene, such as *GAPDH, ACTB* and *18S RNA* ([@ref-22]; [@ref-24]), without evaluating the expression stability of these reference genes. Therefore, it is necessary to estimate the stability of reference genes at various altitudes.

In the present study, eight different reference genes were selected to be assessed and validated for stability at different altitudes using the geNorm, NormFinder, BestKeeper and RefFinder programs. The study identified two candidate genes (*PPIA* and *RPL13A*) that are stably expressed under hypoxic stress and can be used as reference genes for relative gene quantification and normalization before and after entering the plateau region.

In this study, three widely used algorithms (geNorm, NormFinder and BestKeeper) were applied to calculate the stability of the selected reference gene expression levels. The geNorm algorithm uses the principle that the expression ratio of two ideal reference genes is identical in all tested samples ([@ref-27]). According to the average pairwise variation of one reference gene with all other candidate genes, a lower *M*-value indicates greater stability of the candidate gene. NormFinder, which is based on the stability value of the internal control genes, can select the minimally fluctuating genes as the most stable genes, but it can only select one suitable reference gene for normalization. The ranking results varied across the different algorithms. The comprehensive RefFinder ranking indicated that *GAPDH* and *PPIA* were the most stable genes in the plains and plateau groups, respectively, and *PPIA* was the most stable gene in both stages.

Previous studies have reported that *β2-MG* levels do not vary with oxygen concentration ([@ref-20]). Studies in bladder cancer cells under hypoxia showed that *β2-MG* and *Hypoxanthine phosphoribosyltransferase-1* (*HPRT*) were the most suitable reference genes for normalizing gene expression ([@ref-14]). In human retinal endothelial cells, *TBP* and *pumilio RNA binding family member 1* (*PUM1*) were the most stable reference genes under hypoxic conditions ([@ref-29]). However, the present study showed that the stress-specific candidate genes *β2-MG* and *TBP* were not suitable for normalizing target gene expression in blood under normoxic and hypoxic conditions.

Under normoxic conditions, *GAPDH* was the most stable gene in the blood, whereas under hypoxic conditions, *PPIA* was the most stable candidate reference gene. *RPL13A* was ranked as the second most stable reference gene in blood both under normoxic and hypoxic conditions. *ACTB* was observed to be the most stable candidate gene in plain blood using the geNorm algorithm ([Fig. 3B](#fig-3){ref-type="fig"}), but it was the least stable ([Fig. 3A](#fig-3){ref-type="fig"}) in the combined analysis of tested samples. In the plateau stage but not in the plains stage, *18S RNA* was one of the most stable genes. The differences in the reference gene rankings could be associated with the algorithms used by each program.

Our study has some limitations. The identification of stable candidate genes for target gene expression analysis in human blood between low- and high-altitude conditions was a major challenge due to the difficulty involved in sample collection. This difficulty may account for the limited number of volunteers enrolled in the present study and the limited number of gene expression studies of blood in the plateau environment. Thus, one of the limitations of this study was that we could not collect enough blood samples to strengthen the reliability of the present study. In addition, analyses of the stability of reference gene expression should be verified at a cellular level in a hypoxic chamber. In the present study, however, the stability of candidate reference genes was reliably evaluated in blood under normoxic and hypoxic stress conditions using algorithms. Previous studies on target gene expression analyses of blood under hypoxic conditions used *18S RNA* ([@ref-17]) and *β2-MG* ([@ref-20]) as reference genes for normalization. The present study clearly showed that both *PPIA* and *RPL13A* are stable and suitable reference genes, but the amplification efficiency of *PPIA* was more than 1.05 ([Table 2](#table-2){ref-type="table"}). Thus, *RPL13A* is the most suitable and stable reference gene for the normalization of target gene expression in blood from the plains and plateau environments.

In conclusion, the present study determined that *GAPDH* and *RPL13A* in blood from the plains region and *PPIA* and *RPL13A* in blood from the plateau region were the most stable reference genes. Among the identified stably expressed reference genes in both the plains and plateau environments, RPL13A was shown to be most stable in blood from both the normoxic and hypoxic conditions. Additional studies should be conducted on the cellular level to verify the stability of the same reference genes.

Conclusions
===========

In this study, the expression levels of eight candidate human reference genes (*GAPDH*, *ACTB*, *18S RNA*, *β2-MG*, *PPIA*, *RPL13A*, *TBP* and *SDHA*) were assessed in blood from hypoxic environments. We determined, for the first time, that *RPL13A* was the most reliable reference gene for the normalization of target gene expression in human blood from low- and high-altitude environments. However, to obtain reliable data, the use of more than one reference gene is strongly recommended.
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###### *Ct* value of the eight candidate reference genes in blood before and after entering plateau

###### 

Click here for additional data file.
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